Cargando…
Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration
Current projections are that by 2050 the numbers of people aged 65 and older with Alzheimer's disease (AD) in the US may increase threefold while dementia is projected to double every 20 years reaching ~115 million by 2050. AD is clinically characterized by progressive dementia and neuropatholo...
Autores principales: | Festoff, Barry W., Sajja, Ravi K., Cucullo, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584365/ https://www.ncbi.nlm.nih.gov/pubmed/28890893 http://dx.doi.org/10.1155/2017/1549194 |
Ejemplares similares
-
HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
por: Festoff, Barry W., et al.
Publicado: (2016) -
Altered Nrf2 Signaling Mediates Hypoglycemia-Induced Blood–Brain Barrier Endothelial Dysfunction In Vitro
por: Sajja, Ravi K., et al.
Publicado: (2015) -
In vitro characterization of odorranalectin for peptide-based drug delivery across the blood–brain barrier
por: Sajja, Ravi K., et al.
Publicado: (2019) -
Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line
por: Sajja, Ravi K, et al.
Publicado: (2014) -
Impact of cigarette smoke extract and hyperglycemic conditions on blood–brain barrier endothelial cells
por: Prasad, Shikha, et al.
Publicado: (2015)